Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722239 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
ElectronicAdd to Basket



Treatment Algorithms 2002: Hepatitis B and C
Datamonitor, April 2002


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

Treatment Algorithm 2002:Hepatitis B and C is an analysis of the treatment patterns of hepatitis B (HBV) and hepatitis C (HCV) infection, in seven of the worlds major markets, namely the US, Japan, France, Germany, Italy Spain and the UK. The report is based on extensive primary physician research across these regions, and validated through secondary research, with NGOs, government agencies and clinical and research journals. Structure of report: The report is broken down into 4 sections, as described below: * Clinical overview - Complete epidemiological analysis, by incidence and prevalence for the seven major markets. The patient group is analyzed and split by diagnosis and treatment. * Presentation, Screening and Diagnosis - provides a breakdown of physician types involved in presentation, diagnosis and treatment. Screening programs and diagnostic guidelines are analyzed for each country. * Global Treatment patterns - Breakdown of patient share between first line therapy treatment, including dosage amount, frequency and length of therapy. Response and relapse rates to each therapy are provided, along with a further breakdown of second line treatment. Analysis of global treatment patterns and variations are followed by a more in depth view of each of the seven major markets. * Analyst insight - The key impacts on future treatment of HBV and HCV, both from a physician perspective, and from Datamonitors viewpoint. Unmet needs in the treatment of hepatitis are identified, and the health economics of both diseases are discussed, specifically the growth of the diseased population in the major markets, the impact of vaccination on the progression of HBV disease, the increasing significance of HIV comorbidity and the prospective for prophylactic and therapeutic vaccine development for HCV infection.


Customers who bought this item also bought

Treatment Algorithms 2002: Alzheimer's Disease - Aricept: the physicians choice

Treatment Algorithm 2001: Diabetes

Stakeholder Insight: Hepatitis B & C - Winning Battles But Not The War

Treatment Algorithms 2001 Breast Cancer: Herceptin Falling into Stride

Treatment Algorithms 2001: Allergic Rhinitis - Unlocking the Real Patient Potential

Treatment Algorithms 2002: Venous Thromboembolism Acute Therapy

Treatment Algorithms 2001: Prostate Cancer

Treatment Algorithms 2001: Lung Cancer

Treatment Algorithms 2001: Schizophrenia - The Rise of Atypical Neuroleptics as the Physicians’ Favorite

Treatment Algorithms 2002: Heart failure - managing chronic and acute patients

Stakeholder Insight: Neuropathic Pain - Comparative Overview of Treatment Preferences Across the Seven Major Markets

Treatment Algorithms 2000: Rheumatoid Arthritis - Defining Changing Treatment Trends



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds